Compare Humana Inc (HUM) vs Skyworks Solutions Inc (SWKS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Skyworks Solutions Inc — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while Skyworks Solutions Inc trades at $68.28 (market cap $10.35B). The key difference: Humana Inc is far larger — about 4.5× Skyworks Solutions Inc's market cap, and Skyworks Solutions Inc pays the higher dividend (4.13%). Which is the better fit depends on your goals.
| HUM | SWKS | |
|---|---|---|
Market Cap | $46.31B | $10.35B |
Sector | Health | Technology |
52-Week High | $409.42 | $83.40 |
52-Week Low | $163.67 | $52.50 |
Enterprise Value | $53.67B | $10.23B |
Dividend Yield | 0.92% | 4.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Skyworks Solutions (SWKS) trades at $70.62, up 5.66% today, showing strong momentum despite mixed technical signals. The company delivered three consecutive quarterly earnings beats, with Q3 2026 EPS of $1.08 exceeding expectations. Revenue trends show contraction from $5.5B in 2022 to $4.1B in 2025, while profit margins have compressed from 23.24% to 11.67% over the same period. The pending Qorvo combination represents a significant strategic development that could reshape the company's competitive positioning in the semiconductor sector.
The stock presents a complex investment case with strong analyst support (58% buy ratings) but faces revenue headwinds and margin pressure. The $66 consensus price target suggests limited upside from current levels, while the ongoing merger process introduces integration execution risks. Investors must weigh the potential benefits of diversification against the challenges of declining profitability in the core business.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Skyworks Solutions Inc
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →
